PTAB Will Review Amgen Patent Tied To Sanofi Eczema Drug
The Patent Trial and Appeal Board said Thursday it would review a patent owned by Amgen unit Immunex — which Sanofi says stands in the way of its new eczema biologic — with...To view the full article, register now.
Already a subscriber? Click here to view full article